BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23932389)

  • 1. 18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
    Niccoli-Asabella A; Notaristefano A; Rubini D; Altini C; Ferrari C; Merenda N; Fanelli M; Rubini G
    Clin Imaging; 2013; 37(6):1098-103. PubMed ID: 23932389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
    Otsuka H; Terazawa K; Morita N; Otomi Y; Yamashita K; Nishitani H
    J Med Invest; 2009 Feb; 56(1-2):16-20. PubMed ID: 19262009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.
    Bille A; Chicklore S; Okiror L; Cook GJ; Spicer J; Landau D; Lang-Lazdunski L
    Nucl Med Commun; 2013 Nov; 34(11):1075-83. PubMed ID: 23963351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
    Bénard F; Sterman D; Smith RJ; Kaiser LR; Albelda SM; Alavi A
    Chest; 1998 Sep; 114(3):713-22. PubMed ID: 9743156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
    Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A
    Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
    Gerbaudo VH; Mamede M; Trotman-Dickenson B; Hatabu H; Sugarbaker DJ
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):810-21. PubMed ID: 21210110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
    Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L
    J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
    Subramaniam RM; Wilcox B; Aubry MC; Jett J; Peller PJ
    J Med Imaging Radiat Oncol; 2009 Apr; 53(2):160-9; quiz 170. PubMed ID: 19527361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.
    Roca E; Laroumagne S; Vandemoortele T; Berdah S; Dutau H; Maldonado F; Astoul P
    Lung Cancer; 2013 Feb; 79(2):187-90. PubMed ID: 23206832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
    Kitajima K; Doi H; Kuribayashi K
    Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural tuberculosis mimicking malignant pleural mesothelioma by
    Ai L; Wang W; Li Y
    Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
    Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?
    Fernández-Rodríguez P; Martín-Marcuartu JJ; Acevedo Báñez I; Masero Carretero JM; Jiménez-Hoyuela García JM
    Clin Nucl Med; 2020 Mar; 45(3):e148-e150. PubMed ID: 31977466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomas.
    Niccoli-Asabella A; Altini C; Notaristefano A; Merenda N; Altieri ML; Stabile-Ianora AA; Fanelli M; Rubini G
    Nucl Med Commun; 2013 Jan; 34(1):32-9. PubMed ID: 23111380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET/CT: a report of 2 cases.
    Ciarallo A; Makis W; Novales-Diaz JA; Lisbona R
    Clin Nucl Med; 2012 Apr; 37(4):416-9. PubMed ID: 22391723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.